News

Researchers at UC San Francisco and UC San Diego have mapped out how hundreds of mutations involved in two types of cancer affect the activity of proteins that are the ultimate actors behind the disease. The work points the way to identifying new precision treatments that may avoid the side effects

Glioblastoma is the most common malignant brain tumor and among the most treatment-resistant cancers. In the last 15 years, numerous attempts to develop new drugs for glioblastoma have failed. In response, the National Cancer Institute (NCI) has established the Glioblastoma Therapeutics Network (GTN

Cancer cells proliferate despite a myriad of stresses – from oxygen deprivation to chemotherapy – that would kill any ordinary cell. Now, researchers at UC San Francisco have gained insight into how they may be doing this through the downstream activity of a powerful estrogen receptor. The discovery

In response to the recent adoption of the Texas Heartbeat Act (SB8) banning nearly all abortions, the Cancer Center’s Breast Oncology Program members are part of a growing effort to move the annual San Antonio Breast Cancer Symposium (SABCS) out of Texas. The new law, which bans abortions after six

“It is critical that we bring people with diverse perspectives and backgrounds into medicine. Our medical teams must reflect the diversity of our communities in order for patients to have the best possible outcomes,” says Matthew Bucknor, MD, associate chair for wellbeing and professional climate